Publication date: Available online 16 November 2026 Source: Clinical Microbiology and Infection Author(s): Haini Wen, Kai Wiater, Sandrine Marchand, Elin M. Svensson, Lena E. Friberg
Model-informed dosing strategies for inhaled aminoglycosides in nosocomial pneumonia. // Clinical Microbiology and Infection. – URL: https://www.sciencedirect.com/science/article/pii/S1198743X26006427?dgcid=rss_sd_all
Model-informed dosing strategies for inhaled aminoglycosides in nosocomial pneumonia. Clinical Microbiology and Infection. https://www.sciencedirect.com/science/article/pii/S1198743X26006427?dgcid=rss_sd_all
“Model-informed dosing strategies for inhaled aminoglycosides in nosocomial pneumonia.” Clinical Microbiology and Infection.
@article{article40948,
title = {Model-informed dosing strategies for inhaled aminoglycosides in nosocomial pneumonia},
journal = {Clinical Microbiology and Infection},
url = {https://www.sciencedirect.com/science/article/pii/S1198743X26006427?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...